JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evoniuk, G. E.
Right arrow Articles by Wurtman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evoniuk, G. E.
Right arrow Articles by Wurtman, R. J.

Adenosine affects sympathetic neurotransmission at multiple sites in vivo

GE Evoniuk, RW von Borstel and RJ Wurtman

We examined the effects of adenosine and its analogs on sympathomimetic responses of pithed rats to electrical stimulation of preganglionic sympathetic nerves (ES) or to injections of nicotine, phenylephrine (PE) or isoproterenol (ISO). Four physiological indices of sympathetic neurotransmission were measured: blood pressure, heart rate and contractions of smooth muscle in vas deferens and eyelid. Elevation of arterial adenosine levels from 1.5 to 2 to 3 microM caused a 2- to 3- fold potentiation of nicotine-induced increases in blood pressure, heart rate and smooth muscle tension. Higher adenosine concentrations (3-4 microM) produced a smaller potentiation of the effects of nicotine. At 2 to 3 microM, adenosine had no effect on sympathomimetic responses to ES or PE. Higher concentrations (3-4 microM) attenuated pressor responses to ES and PE and the contractile responses of the vas deferens to ES; these levels also potentiated positive chronotropic responses to ISO. The adenosine analogs N-cyclopropylcarboxamido adenosine (N-CPCA), 2-chloroadenosine (2-CLA) and R- and S- phenylisopropyl adenosine (R-PIA and S-PIA) also reduced pressor responses to both ES and PE, with the potency order: N-CPCA greater than R-PIA greater than 2-CLA greater than S-PIA. These analogs exhibited this same potency series in attenuating contractile responses to ES in the vas deferens. However, all four analogs potentiated, at the lower doses tested, the contractile response of the vas deferens to PE; at higher concentrations, inhibition predominated. N-CPCA enhanced the chronotropic effects of ISO and ES.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 236, Issue 2, pp. 350-355, 02/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1986 by the American Society for Pharmacology and Experimental Therapeutics.